Treatment with dihydroethidium reduces infarct size after transient focal cerebral ischemia in mice

Brain Research

Volumn 978, Issue 1-2, 2003, Pages 223-227

  Yu, Fengshan ^a   Sugawara, Taku ^a   Chan, Pak H ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Delayed treatment; Dihydroethidium; Focal cerebral ischemia; Neuroprotection; Stroke; Superoxide anion

Indexed keywords

ETHIDIUM; HYDROETHIDINE; SUPEROXIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INFARCTION; BRAIN ISCHEMIA; BRAIN PERFUSION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; MALE; MOUSE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; REPERFUSION; STROKE; TRANSIENT ISCHEMIC ATTACK; TREATMENT OUTCOME;

EID: 0038771196     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(03)02775-6     Document Type: Article

References (22)

1. Becker L.B., vanden Hoek T.L., Shao Z.H., Li C.Q., Schumacker P.T. Generation of superoxide in cardiomyocytes during ischemia before reperfusion. Am. J. Physiol. 277:1999;H2240-H2246.
2. Bederson J.B., Pitts L.H., Tsuji M., Nishimura M.C., Davis R.L., Bartkowski H. Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke. 17:1986;472-476.
3. Benov L., Sztejnberg L., Fridovich I. Critical evaluation of the use of hydroethidine as a measure of superoxide anion radical. Free Radic. Biol. Med. 25:1998;826-831.
4. Bindokas V.P., Jordán J., Lee C.C., Miller R.J. Superoxide production in rat hippocampal neurons: selective imaging with hydroethidine. J. Neurosci. 16:1996;1324-1336.
5. Chan P.H., Kawase M., Murakami K., Chen S.F., Li Y., Calagui B., Reola L., Carlson E., Epstein C.J. Overexpression of SOD1 in transgenic rats protects vulnerable neurons against ischemic damage after global cerebral ischemia and reperfusion. J. Neurosci. 18:1998;8292-8299.
6. Dröge W. Free radicals in the physiological control of cell function. Physiol. Rev. 82:2002;47-95.
7. Fujimura M., Morita-Fujimura Y., Narasimhan P., Copin J.-C., Kawase M., Chan P.H. Copper-zinc superoxide dismutase prevents the early decrease of apurinic/apyrimidinic endonuclease and subsequent DNA fragmentation after transient focal cerebral ischemia in mice. Stroke. 30:1999;2408-2415.
8. Fujimura M., Morita-Fujimura Y., Noshita N., Sugawara T., Kawase M., Chan P.H. The cytosolic antioxidant copper/zinc-superoxide dismutase prevents the early release of mitochondrial cytochrome c in ischemic brain after transient focal cerebral ischemia in mice. J. Neurosci. 20:2000;2817-2824.
9. Gilgun-Sherki Y., Rosenbaum Z., Melamed E., Offen D. Antioxidant therapy in acute central nervous system injury: current state. Pharmacol. Rev. 54:2002;271-284.
10. Kalivendi S.V., Kotamraju S., Zhao H., Joseph J., Kalyanaraman B. Doxorubicin-induced apoptosis is associated with increased transcription of endothelial nitric-oxide synthase. Effect of antiapoptotic antioxidants and calcium. J. Biol. Chem. 276:2001;47266-47276.
11. Keller J.N., Kindy M.S., Holtsberg F.W., St. Clair D.K., Yen H.-C., Germeyer A., Steiner S.M., Bruce-Keller A.J., Hutchins J.B., Mattson M.P. Mitochondrial manganese superoxide dismutase prevents neural apoptosis and reduces ischemic brain injury: suppression of peroxynitrite production, lipid peroxidation, and mitochondrial dysfunction. J. Neurosci. 18:1998;687-697.
12. Kim G.W., Chan P.H. Oxidative stress and neuronal DNA fragmentation mediate age-dependent vulnerability to the mitochondrial toxin, 3-nitropropionic acid, in the mouse striatum. Neurobiol. Dis. 8:2001;114-126.
13. Kim G.W., Kondo T., Noshita N., Chan P.H. Manganese superoxide dismutase deficiency exacerbates cerebral infarction after focal cerebral ischemia/reperfusion in mice. Implications for the production and role of superoxide radicals. Stroke. 33:2002;809-815.
14. Kobzik L., Godleski J.J., Brain J.D. Oxidative metabolism in the alveolar macrophage: analysis by flow cytometry. J. Leukocyte Biol. 47:1990;295-303.
15. Kondo T., Reaume A.G., Huang T.-T., Carlson E., Murakami K., Chen S.F., Hoffman E.K., Scott R.W., Epstein C.J., Chan P.H. Reduction of CuZn-superoxide dismutase activity exacerbates neuronal cell injury and edema formation after transient focal cerebral ischemia. J. Neurosci. 17:1997;4180-4189.
16. Lewén A., Sugawara T., Gasche Y., Fujimura M., Chan P.H. Oxidative cellular damage and the reduction of APE/Ref-1 expression after experimental traumatic brain injury. Neurobiol. Dis. 8:2001;380-390.
17. Lotharius J., O'Malley K.L. The parkinsonism-inducing drug 1-methyl-4-phenylpyridinium triggers intracellular dopamine oxidation. A novel mechanism of toxicity. J. Biol. Chem. 275:2000;38581-38588.
18. Noshita N., Lewén A., Sugawara T., Chan P.H. Evidence of phosphorylation of Akt and neuronal survival after transient focal cerebral ischemia in mice. J. Cereb. Blood Flow Metab. 21:2001;1442-1450.
19. Sheng H., Bart R.D., Oury T.D., Pearlstein R.D., Crapo J.D., Warner D.S. Mice overexpressing extracellular superoxide dismutase have increased resistance to focal cerebral ischemia. Neuroscience. 88:1999;185-191.
20. Sheng H., Brady T.C., Pearlstein R.D., Crapo J.D., Warner D.S. Extracellular superoxide dismutase deficiency worsens outcome from focal cerebral ischemia in the mouse. Neurosci. Lett. 267:1999;13-16.
21. Sugawara T., Noshita N., Lewén A., Gasche Y., Ferrand-Drake M., Fujimura M., Morita-Fujimura Y., Chan P.H. Overexpression of copper/zinc superoxide dismutase in transgenic rats protects vulnerable neurons against ischemic damage by blocking the mitochondrial pathway of caspase activation. J. Neurosci. 22:2002;209-217.
22. Yang G., Chan P.H., Chen J., Carlson E., Chen S.F., Weinstein P., Epstein C.J., Kamii H. Human copper-zinc superoxide dismutase transgenic mice are highly resistant to reperfusion injury after focal cerebral ischemia. Stroke. 25:1994;165-170.